Sign in

CIK 0001674416 · Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
operating
EIN
473173478
Phone
6173154600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
  1. 8-K Event Executive or director change · Regulation FD disclosure
  2. SC 13D/A Stake Beneficial Ownership Report
  3. SC 13G/A Stake Amended Statement of Ownership
  4. 10-K Report Annual Report
  5. 8-K Event Results of operations
  6. SC 13G Stake Amended Statement of Ownership
  7. SC 13G Stake Amended Statement of Ownership
  8. SC 13D/A Stake Beneficial Ownership Report
  9. 8-K Event Executive or director change
  10. SC 13D/A Stake Beneficial Ownership Report
  11. SC 13D/A Stake Beneficial Ownership Report
  12. 8-K Event Agreement ended · Executive or director change
  13. 4 Option exercise Chief Executive Officer acquired 8,000 shares (option exercise)
  14. 8-K Event Material agreement · Agreement ended · Acquisition or sale completed
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Shares withheld for taxes Chief Executive Officer gave up 741 shares (to pay taxes)

Page 27 of 45 · 883 filings